Cannabinoid emulsifier

A formulation comprising:

• a compound defined by General Formula:
• wherein:
• R1-R10 are independently selected from H or an alkyl of 1-10 carbons;
• alkenyl of up to 10 carbons;
• or groups on adjacent carbons may be taken together to form an alkene;
• R11 represents —(CH2CHR16O)x—R17 or R11 and R10 may be taken together to represent C(R19)2;
• R12 represents —(CH2CHR16O)x—R17;
• R13-R15 independently represent H or an alkyl of 1-8 carbons;
• each R16 independently represents H or an alkyl of 1-3 carbons;
• each R17 independently represents H, an alkyl or substituted alkyl of 1-22 carbons, aryl or substituted aryl or the ester of an acid;
• each R19 independently represents H or an alkyl of 1-5 carbons;
• and
• each x is independently an integer of 1-100;
• and
• a cannabinoid.

A formulation comprising:

• a compound defined by General Formula:
• wherein:
• R1-R10 are independently selected from H or an alkyl of 1-10 carbons;
• alkenyl of up to 10 carbons;
• or groups on adjacent carbons may be taken together to form an alkene;
• R11 and R12 are independently —(CH2CHR16O)xR17—;
• R11 and R10 may be taken together to represent C(R19)2—;
• R13-R15 independently represent H or an alkyl of 1-8 carbons;
• each R16 independently represents H or an alkyl of 1-3 carbons;
• each R17 independently represents H, an alkyl or substituted alkyl of 1-22 carbons, aryl or substituted aryl or the ester of an acid;
• each R19 independently represents H or an alkyl of 1-5 carbons;
• and
• each x is independently an integer of 1-100;
• and
• a cannabinoid wherein said cannabinoid is selected from the group consisting of cannabidiol (CBD), tetrahydrocannabinol (THC), cannabichromene (CBC), cannabichromevarin (CBCV), cannabidiphorol (CBDP), cannabidivarinic acid (CBDVA), cannabielsoin (CBEA), cannabigerolic acid (CBCA), cannabigerolic acid monomethyl ether (CBGAM), cannabigerovarinic acid (CBGVA), cannabicyclolic acid (CBLA), cannabinolic acid (CBNA), cannabicitranic acid (CBTA), cannabivarinic acid (CBVA), tetrahydrocannabinolic acid (THCA), tetrahydrocannabiorcolic acid (THCCA), tetrahydrocannabiphorolic acid (THCPA), tetrahydrocannabivarinic acid (THCVA), cannabidivarin (CBDV), cannabielsoin (CBE), cannabigerol (CBG), cannabigerol monomethylether (CBGM), cannabigerovarin (CBGV), cannabicyclol (CBL), cannabinol (CBN), cannabicitran (CBTC), cannabivarin (CBV), tetrahydrocannabiorcol (THCC), tetrahydrocannabiphorol (THCP) and tetrahydrocannabivarin (TNCV).

A method for treating tissue comprising applying a formulation comprising:

• a compound defined by General Formula:
• wherein:
• R1-R10 are independently selected from H or an alkyl of 1-10 carbons;
• alkenyl of up to 10 carbons;
• or groups on adjacent carbons may be taken together to form an alkene;
• R11 and R12 are independently —(CH2CHR16O)xR17—;
• R11 and R10 may be taken together to represent C(R19)2;
• R13-R15 independently represent H or an alkyl of 1-8 carbons;
• each R16 independently represents H or an alkyl of 1-3 carbons;
• each R17 independently represents H, an alkyl or substituted alkyl of 1-22 carbons, aryl or substituted aryl or the ester of an acid;
• each R19 independently represents H or an alkyl of 1-5 carbons;
• and
• each x is independently an integer of 1-100;
• and
• a cannabinoid.